New algorithm determines ideal caffeine dosage and timing for alertness
According to a recent study, a newly developed algorithm may be the key to optimizing alertness with caffeine. Caffeine is the most widely consumed stimulant...
According to a recent study, a newly developed algorithm may be the key to optimizing alertness with caffeine. Caffeine is the most widely consumed stimulant...
Pilot data from a recent study suggest that sleep paralysis and dream-like hallucinations as you are falling asleep or waking up are widespread in student...
Data from Ongoing Phase 2 Study to be Presented at 1:15 PM CT at the 2018 American Society of Clinical Oncology (ASCO) Annual Meeting Of...
DALLAS, June 4, 2018 --Limited healthy literacy is a major barrier blocking many people from achieving good cardiovascular health or benefiting from effective treatment for...
Credit: Anne M. Merks, MDC When it first starts to develop, the heart is a simple tube. Reporting in the journal Nature Communications, researchers at...
Credit: Izumi Mindy Takamiya Fuyuhiko Tamanoi of Kyoto University's Institute for Integrated Cell-Material Sciences (iCeMS) and colleagues in the US succeeded in establishing a versatile,...
A new study has identified important factors that can improve the transfer of patients from the intensive care unit (ICU) to a general hospital ward,...
A key recommendation in a new Canadian guideline on managing chronic hepatitis C virus (HCV) is to screen all people born between 1945 and 1975...
Inadequate sleep is a public health problem affecting more than one in three adults worldwide. A new study in the journal SLEEP, published by Oxford...
PHILADELPHIA - In a finding that suggests the potential for practice change that would reduce the use of antibiotics in dermatology, researchers in the Perelman...
Credit: University of Colorado Cancer Center Updated results of the global phase III ALEX trial comparing alectinib with crizotinib as first-line treatment against ALK-positive non-small...
Credit: University of Colorado Cancer Center The drug crizotinib has activity against a number of genetic targets relevant to non-small cell lung cancer, already earning...
Credit: University of Colorado Cancer Center Survival results for the CALGB 80303 Trial presented today at the American Society of Clinical Oncology (ASCO) Annual Meeting...
One of the favourites in soccer's upcoming 2018 FIFA World Cup, Germany, has just 13.3% chance of winning. And Australia has 14% chance of getting...
New findings from the groundbreaking Trial Assigning Individualized Options for Treatment (Rx), or TAILORx trial, show no benefit from chemotherapy for 70 percent of women...
We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.
Bioengineer.org © Copyright 2023 All Rights Reserved.
Bioengineer.org © Copyright 2023 All Rights Reserved.